Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Human amnion epithelial cells modulate the inflammatory response to ventilation in preterm lambs

  • Jacqueline M. Melville,

    Affiliation The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia

  • Courtney A. McDonald,

    Affiliation The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia

  • Robert J. Bischof ,

    Affiliation The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia

  • Graeme R. Polglase,

    Affiliations The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia, Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia

  • Rebecca Lim,

    Affiliations The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia, Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia

  • Euan M. Wallace,

    Affiliations The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia, Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia

  • Graham Jenkin,

    Affiliations The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia, Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia

  • Timothy J. Moss

    Affiliations The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia, Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia

Human amnion epithelial cells modulate the inflammatory response to ventilation in preterm lambs

  • Jacqueline M. Melville, 
  • Courtney A. McDonald, 
  • Robert J. Bischof, 
  • Graeme R. Polglase, 
  • Rebecca Lim, 
  • Euan M. Wallace, 
  • Graham Jenkin, 
  • Timothy J. Moss


Ventilation of preterm neonates causes pulmonary inflammation that can contribute to lung injury, propagate systemically and result in long-term disease. Modulation of this initial response may reduce lung injury and its sequelae. We aimed to determine the effect of human amnion epithelial cells (hAECs) on immune activation and lung injury in preterm neonatal lambs. Preterm lambs received intratracheal hAECs (90x106) or vehicle, prior to 2 h of mechanical ventilation. Within 5 min of ventilation onset, lambs also received intravenous hAECs (90x106) or vehicle. Lung histology, bronchoalveolar lavage (BAL) cell phenotypes, and cytokine profiles were examined after 2 h of ventilation, and in unventilated controls. Histological indices of lung injury were higher than control, in vehicle-treated ventilated lambs but not in hAEC-treated ventilated lambs. Ventilation-induced pulmonary leukocyte recruitment was greater in hAEC-treated lambs than in vehicle-treated lambs. Lung IL-1β and IL-6 mRNA expression was higher in vehicle- and hAEC-treated ventilated lambs than in controls but IL-8 mRNA levels were greater than control only in vehicle-treated ventilated lambs. Numbers of CD44+ and CD21+ lymphocytes and macrophages from the lungs were altered in vehicle- and hAEC-treated ventilated lambs. Numbers of CD8+ macrophages were lower in hAEC-treated ventilated lambs than in vehicle-treated ventilated lambs. Indices of systemic inflammation were not different between vehicle- and hAEC-treated lambs. Human amnion epithelial cells modulate the pulmonary inflammatory response to ventilation in preterm lambs, and reduce acute lung injury. Immunomodulatory effects of hAECs reduce lung injury in preterm neonates and may protect against longer-term respiratory disease.


Assisted or mechanical ventilation at birth is required by about 1 in 10 neonates [1], and is often provided in the form of intermittent positive pressure ventilation [2]. Such ventilation, while needed, causes inadvertent lung injury and long-term respiratory disease in some babies [3]. Such injury may contribute to development of bronchopulmonary dysplasia (BPD) [4].

Mechanical ventilation can result in airway inflammation and elevated pulmonary mRNA expression of inflammatory mediators, including serum amyloid A3 (SAA-3), interleukin (IL)-1β and IL-6, within 1 h of ventilation [5, 6]. Activation of circulating CD4+ and CD8+ T cells occurs in preterm infants with BPD [7], however, the absolute lymphocyte number is decreased, owing to a decrease in circulating CD4+ cells [8]. This initial inflammatory response to ventilation may influence development of lung injury [9, 10]. Prevention or attenuation of early detrimental responses to mechanical ventilation, through immunomodulation, may therefore reduce the risk of development of BPD [11].

One potential immunomodulatory therapy for BPD is administration of stem cell–like human amnion epithelial cells (hAECs). Epithelial cells of the amnion can differentiate into ectodermal, mesodermal and endodermal lineages [1214], and into lung epithelial–like cells in vitro [15, 16] and in vivo [17]. Administration of hAECs reduces inflammatory gene expression in lung tissue and prevent inflammation-induced changes in fetal lung development induced by either intra-amniotic injection of lipopolysaccharide [18] or a 12-h period of mechanical ventilation in utero [17] in sheep. Human AECs can also moderate abnormal lung development in hyperoxic neonatal mice [19], but their ability to influence ventilation-induced lung inflammation and injury in neonates has not been examined.

We hypothesised that administration of hAECs to ventilated preterm lambs would reduce lung injury, and pulmonary and systemic inflammatory responses.

Materials and methods

Human amnion epithelial cell isolation and preparation

Human procedures (including the consent process) were approved by the Monash Health Human Research and Ethics Committee (ref #: MUHREC-CF13/2144-2013001109). Placentae were obtained from women with uncomplicated pregnancies who provided written consent before elective caesarean section at term (37–40 weeks). Amnion epithelial cells were isolated as previously described [20]. Cell counts and viability were assessed by trypan blue exclusion prior to and after cryopreservation. For treatment of preterm lambs, hAECs from three donors were thawed and combined, washed, counted and assessed for viability, then resuspended at 30x106 cells/ml in sterile phosphate-buffered saline (PBS) for administration.

Animal experiments

Animal experimentation was approved by the relevant Monash University Animal Ethics Committee (ref #: MMCA/2012/10).

Experimental animals were obtained from a timed mating program managed by the Monash Animal Research Platform, Monash University. They were transported from an open filed environment to indoor housing (12 h light/dark cycle) in individual pens at least 1 week before any experimental intervention. Ewes remained in constant visual contact of other sheep, had continual access to water and were fed a pelleted diet, supplemented with chaff and/or lucerne hay, twice daily.

For the laparotomy procedure, ewes bearing twins at 126 ± 1 (mean ± SD) days of gestation (term ~147 days) were anaesthetised (2% isoflurane in O2, delivered by positive-pressure ventilation, after induction by IV injection of 20mg/kg sodium thiopentone). A surgical monitor (Surgivet Advisor, Smiths Medical, MA, USA) was used for continual monitoring of ewes’ ECG, heart rate, O2 saturation (by pulse oximetry) and end-tidal CO2. A protocol was in place for an escalating series of interventions should there be deterioration in any of these physiological indices of wellbeing (culminating in immediate euthanasia for severe respiratory or cardiovascular crisis); however all ewes remained well throughout the procedure.

A laparotomy was performed, the fetus was exposed and the trachea orally intubated (using a cuffed 4.0-mm endotracheal tube), excess lung liquid was drained. A pulse oximeter probe (Masimo, Irvine, CA, USA) was placed on the right forelimb. The fetus then received an intratracheal infusion of 90x106 hAECs (in 3 ml PBS) or vehicle (3ml PBS) and the endotracheal tube was clamped until ventilation onset.

The umbilical cord was clamped and cut. The ewe was immediately killed (by IV injection of 5g pentobarbitone) while anaesthetised. The lamb was weighed, dried and placed in a supine position on an infant warmer (Fisher and Paykel Healthcare, Auckland, New Zealand). Each lamb was connected to a mechanical ventilator (Babylog 8000+ ventilator; Dräger, Lübeck, Germany) for ventilation with warmed (37°C) humidified gas with an initial FiO2 of 0.21, a rate of 60 breaths/min and an inspiratory time of 0.3 sec. Peak inflation pressure (PIP) was adjusted to target a tidal volume (VT) of 15 ml/kg for 15 min without positive end-expiratory pressure (PEEP), but was limited to 45 cmH2O. This ventilation regimen was chosen to induce injury [21], so surfactant was not administered in order not to confound the experimental approach.

The umbilical vein was catheterised for intravenous administration of 90x106 hAECs (in 3 ml PBS) or vehicle (3 ml PBS) within 5 min of delivery, and subsequent infusion of alfaxan (rate of 5–15 mg/kg/h; CenVet, Lynbrook, VIC, Australia) for sedation. We showed previously that combined intratracheal and intravenous administration of 90x106 hAECs (via each route) was most effective for modulation of the fetal pulmonary response to intrauterine inflammation [18]. The umbilical artery was catheterised to continually record arterial pressure and heart rate (DTX Plus Transducer; Becton Dickinson, Singapore: Powerlab; ADInstruments, Castle Hill, NSW, Australia), and for intermittent blood sampling. A pulse oximeter (Masimo, Irvine, CA, USA) was attached to the right forelimb (after removal of hair using small animal clippers) for continual measurement of transcutaneous O2 saturation (SpO2).

Following the initial 15-min ventilation period lambs were ventilated, targeting a VT of 7 ml/kg, for a further 1 h and 45 min, with 4 cmH2O PEEP. Arterial blood gases were measured at 5-min intervals for the first 15 min, followed by 15-min intervals until completion of the experiment at 2 h (ABL30, Radiometer, Copenhagen, Denmark). The inspired O2 content was titrated to maintain arterial O2 saturation (SaO2) between 88–95%. A protocol was in place for immediate euthanasia should lambs’ respiratory or cardiovascular status deteriorate sufficiently but physiological variables for all lambs remained within acceptable ranges: no lamb died or required euthanasia before the end of the 2-h ventilation period.

At the completion of the 2-h ventilation period a final blood sample was then collected for analysis of blood leukocyte phenotype, plasma cytokines, and for T cell proliferation assays. Lambs were killed, with IV pentobarbitone (100 mg/kg; Lethabarb, Virbac Pty Ltd, Australia), for tissue collection. In addition, tissues were collected from unventilated ‘control’ lambs immediately after delivery. These control lambs did not breathe before they were humanely killed as described above.

Ventilatory and blood pressure analysis

Physiological variables were recorded and analysed using LabChart (ADInstruments). Heart rate (HR), peripheral oxygen saturation (SpO2), mean arterial blood pressure (MAP), VT (ml/kg body weight), PIP and PEEP were averaged over 10-s epochs at 5, 10, 15, 30, 45, 60, 75, 105 and 120 min. Lung compliance was calculated: Compliance (ml/cmH2O/kg) = (VT)/(PIP-PEEP).

Tissue analysis

Bronchoalveolar lavage (BAL) fluid collected at post mortem [22], was centrifuged to collect cells for phenotypic analysis by flow cytometry (FACS). The right cranial lung lobe was fixed at 20 cmH2O with 4% paraformaldehyde (PFA) and processed for light microscopic analyses. Lung tissue was sectioned at 5 μm and stained with haematoxylin and eosin. A total of 15 random high-power fields were scored using an established scale [23] for assessment of airway wall thickness, haemorrhage and epithelial sloughing by an investigator blinded to experimental group. Tissue sections were immunostained to count CD45+ cells (MCA2220PE, AbD Serotec, UK), as previously described [24].

Separate lung sections were used to identify cells producing IL-8. These underwent antigen retrieval by heating in 0.01M sodium citrate (pH = 6) in a microwave oven (900W) until simmering, then power output was gradually reduced over 7 min. Sections were cooled, endogenous peroxidase was blocked (0.6% H2O2 in distilled H2O for 20 min) and non-specific binding blocked by incubation in 10% normal goat serum/2% bovine serum albumin (BSA) for 30 min. Slides were incubated with an antibody to ovine IL-8 (mouse anti-ovine IL-8, AbD Serotec MCA1660, clone 8M6, diluted 1:4000 in Dako S0809 antibody diluent) overnight at 4°C, washed (0.1% Tween20 in TBS, 3 x 5-min) and incubated with goat anti-mouse IgG (1:500 in Dako S0809 antibody diluent) for 60 min. Sections were washed before incubation in ABC complex (Vectastain ABC kit; Vector Laboratories) for 45 min. Sections were washed and immunostaining was visualized by incubation with 3,3-diaminobenzidine. Sections were counterstained with hematoxylin. Images from 20 non-overlapping fields (400 x 400 μm) from each section were captured at 20x magnification with Aperio software. Quantification of IL-8 immunohistochemistry was performed using Image-Pro Plus (Media Cybernetics). For each field of view, the number of IL-8+ cells was counted, and a mean for each animal was calculated.

The right middle lobe was placed into ice-cold RPMI-10 media (RPMI supplemented with 10% FBS and 1% penicillin/ streptomycin; Life Technologies) for quantification of immune cells by FACS as detailed previously [25]. Samples of spleen and posterior mediastinal lymph node (PMLN) were also collected in RPMI-10 for cell quantification by FACS, and for T cell isolation for proliferation assays. Sections of the right caudal lung lobe were frozen in liquid N2 and stored at -80°C until required for quantitative real-time polymerase chain reaction (qRT-PCR) analysis.

Blood sampling and leukocyte isolation

Blood was collected into heparinised tubes. Plasma and cells were separated by centrifugation. Plasma was frozen at -80°C, and buffy coat cells (leukocytes) collected for T cell proliferation assays [26]. For spleen, PMLN and lung, single-cell leukocyte suspensions were obtained by dissociating whole tissue through a 70-μm cell strainer (BD Biosciences, CA, USA) in complete RPMI-1640; red blood cells were lysed (lysis buffer; 155mM NH4Cl, 10mM KHCO3, 0.1mM EDTA) and cell number and viability assessed by trypan blue exclusion.

Proliferation assays

Cells from PMLN, spleen and blood were seeded in triplicate in 96-well plates (2.5x105/well) in complete RPMI-1640 medium alone or in the presence of PMA (Phorbol 12-myristate 13-acetate, 20 pg/ml; Sigma-Aldrich, USA) and ionomycin (I; 800 ng/ml; Sigma-Aldrich). Cells were incubated at 37°C for 96 h, followed by addition of 1 μCi/well of [3H]-thymidine (Perkin Elmer, Waltham, MA, USA) for a further 18 h. Cells were harvested onto glass-fibre filter mats (Perkin Elmer) and incorporated radioactive nucleic acids counts performed using a Top Count Harvester (Packard Biosciences, CT, USA), and stimulation index (SI; 3[H]-thymidine uptake in stimulated cells relative to media alone) calculated.

Flow cytometry

BAL cells were stained using single-colour immunofluorescence and analysed on a FACSCanto II flow cytometer (BD Biosciences). Macrophage and lymphocyte populations were gated on forward and side scatter followed by analysis of the fluorescent staining profile [25]. Briefly, cells were incubated with mouse anti-ovine monoclonal antibodies against sheep cell surface molecules CD4, CD8, CD21, CD25, CD44, MHC II and 86D (γδ-T cell), using antibodies detailed elsewhere [25], for 20 min at 4°C and washed with PBS containing 1% BSA, followed by incubation with a fluorescein-conjugated secondary antibody (goat anti-mouse IgG; AlexaFluor 647, Invitrogen) for 20 min at 4°C. Cells were washed again, fixed with 4% PFA prior to acquisition, and analysed using FlowJo software (TreeStar Inc, Ashland, OR, USA).

Plasma cytokine ELISA

Plasma cytokines were measured by enzyme-linked immunosorbent assay (ELISA), as detailed elsewhere [27, 28]. Briefly, 96-well flat-bottom plates (Nunc) were coated with antibody specific for IL-6 (mouse anti-ovine IL-6; 4B6, Epitope Technologies), IL-10 (mouse anti-bovine IL-10; CC318, Serotec) and TNF (mouse anti-ovine TNF; in-house) and incubated with plasma (diluted 1:1 in PBS/1% BSA/0.05% Tween 20) for 1 h at room temperature. After washing, detecting antibodies for IL-6 (polyclonal rabbit anti-ovine IL-6; in-house), IL-10 (biotinylated mouse anti-bovine IL-10; CC320, Serotec) or TNF (polyclonal rabbit anti-ovine TNF; in-house) were added for 1 h at room temperature prior to incubation with horseradish peroxidase (HRP)-conjugated swine anti-rabbit immunoglobulin (Ig, Dako) for IL-6 and TNF, or streptavidin-HRP conjugated Ig (Dako) for IL-10, for 1 h at room temperature. After further washing, plates were incubated with tetramethylbenzidine substrate solution (TMB, Invitrogen) for 15–20 min in the dark at room temperature. Reactions were stopped with the addition of 2M H2SO4 and optical density (OD450) read (Benchmark PlusTM Microplate reader; BioRad, CA, USA). Recombinant ovine IL-6 (in-house), bovine IL-10 (G. Entrican, Moredun, Scotland) and ovine TNF (in-house) were used for standard curves [27].

Quantitative real-time PCR (qRT-PCR)

Messenger RNA for ovine IL-1β, IL-6, IL-8, connective tissue growth factor (CTGF), early growth response protein 1 (EGR1) and cysteine-rich angiogenic inducer 61 (CYR61) were measured in lung tissue. Messenger RNA (mRNA) for serum amyloid A-3 (SAA-3), C-reactive protein (CRP) and hepcidin were measured in liver tissue. RNA was isolated using an extraction kit (RNeasy maxi (lung) or midi (liver) kit; Qiagen, VIC, Australia) as per manufacturer’s instructions. Complementary DNA was transcribed using the Superscript III reverse transcription kit (Life Technologies) as per manufacturer’s instructions. Relative gene expression was quantified by qRT-PCR using the housekeeping gene 18S and ΔCt method of analysis. Data are expressed as relative change from the mean level in the unventilated control group.

Statistical analyses

Data were analysed using one-way ANOVA and Bonferroni post hoc analysis, or Kruskal-Wallis ANOVA on ranks and Dunn’s post hoc test, to compare unventilated control, and vehicle- or hAEC-treated ventilated groups. When comparing serial data between vehicle- and hAEC-treated groups, a two-way repeated measures ANOVA with Holm-Sidak post hoc analysis was used. Where raw data were not normally distributed, they were transformed to achieve normality for analysis. Data were analysed using SPSS v20 statistical analysis software (IBM, Armonk, NY, USA) or GraphPad Prism (GraphPad Software Inc., La Jolla, CA, USA). Data are expressed as mean ± standard error of the mean (SEM).


Measurements at birth and responses to ventilation

Numbers of lambs in each group, fetal arterial blood gas status, birth weight and ratio of males to females were similar between groups (Table 1).

Over the 2 h ventilation period there were no differences in blood gas parameters (pH, PaCO2, PaO2 and SaO2) between vehicle- and hAEC-treated groups (Fig 1A–1D). Heart rate (Fig 2A) was lower at 120 min than at other times after the onset of ventilation (p < 0.001) in all lambs. SpO2, tidal volume, PIP and MAP were not different between vehicle- and hAEC-treated ventilated lambs (Fig 2B–2E). Lung compliance in hAEC-treated lambs tended lower than in vehicle-treated lambs (p = 0.08; Fig 2F).

Fig 1. Blood gas measurements.

Arterial pH (pHa; A), Partial pressure of carbon dioxide (PaCO2; B) and oxygen (PaO2; C), and arterial oxygen saturation (SaO2; D) of vehicle- (open circles; n = 10) and hAEC-treated (closed circles; n = 7) lambs over 2 h of ventilation. Dotted line represents end of injurious ventilation. Data are mean ± SEM.

Fig 2. Physiological parameters during ventilation.

Heart rate (A), mean arterial pressure (B), peripheral oxygen saturation (C), tidal volume (D), peak inspiratory pressure (PIP; E) and dynamic respiratory system compliance (F) of vehicle- (open circles; n = 10) and hAEC-treated lambs (closed circles; n = 7). Dotted line represents end of injurious ventilation. Data are mean ± SEM.

Umbilical arterial plasma concentrations of TNF, IL-6 and IL-10 were comparable between control, vehicle- and hAEC-treated groups before ventilation (TNF and IL-6 data shown in S1 Table). Plasma IL-10 levels at the end of the 2-h ventilation period were higher than before ventilation in the vehicle- and hAEC-treated groups (p<0.001; Fig 3); values tended higher in hAEC-treated lambs than in the vehicle-treated group. Plasma TNF and IL-6 concentrations were not altered by ventilation, and were not different between vehicle- and hAEC-treated groups.

Fig 3. Plasma IL-10 concentrations of unventilated control lambs (grey bars; n = 6), and vehicle- (n = 5) and hAEC-treated (n = 6) ventilated lambs (before and after ventilation).

P value refers to comparison with groups indicated by lines. Data are mean ± SEM biological units (BU)/ml (where one BU of ovine IL-10 shows 50% inhibition of IFNγ production in blood cell cultures [29]).

Characterization of immune cells in BAL

Immune cell proportions from BAL samples are shown in Fig 4. The proportion of CD8+ macrophages from BAL was higher in vehicle-treated lambs than in hAEC-treated lambs (Fig 4B). Proportions of CD21+ lymphocytes and macrophages in BAL were higher in vehicle-treated lambs than in unventilated controls; the proportion of CD21+ lymphocytes (B cells), but not macrophages, was higher than control in hAEC-treated lambs (Fig 4C). The percentage of total CD44+ cells in BAL, as well as CD44+ lymphocytes and macrophages, was greater than control in vehicle- and hAEC-treated lambs, with values tending higher in the hAECs group (Fig 4G). Proportions of CD4+ (Fig 4A), gamma delta+ (γδ+ T cell subpopulation; Fig 4D), CD25+ (T cells expressing the IL-2 receptor, a marker of T cell activation; Fig 4E) or MHC II+ (Fig 4F) cells in BAL were not different between groups.

Fig 4. Cell phenotypes in bronchoalveolar lavage fluid samples.

CD4+ (A), CD8+ (B), CD21+ (C), γδ+ (D), CD25+ (E), CLII+ (F) and CD44+ expression of total BAL cells (white bars), lymphocytes (light grey), macrophages (dark grey) and granulocytes (black bars; panel F only) of control (n = 6), vehicle- (n = 5) and hAEC-treated ventilated lambs (n = 6). #p < 0.05 vs. same cell type in vehicle-treated ventilated group, ##p < 0.01 vs. same cell type in vehicle-treated ventilated group, ** p < 0.01 vs. same cell type in control group. Data are mean ± SEM.

Lung inflammatory gene expression

Levels of mRNA for IL-1β (Fig 5A) and IL-6 (Fig 5B) were higher than control in lung tissue from vehicle- (p = 0.049 and p = 0.020 respectively) and from hAEC-treated lambs (p < 0.008 and p = 0.029 respectively), but were not different between these 2 ventilated groups. IL-8 mRNA levels (Fig 6A) were higher than control in vehicle-treated lambs (p = 0.006), but not in hAEC-treated lambs. Levels of mRNA for early lung injury response genes CYR61 (Fig 5C) and EGR1 (Fig 5D) were higher than control in vehicle-treated (p = 0.010 and p = 0.013 respectively) and in hAEC-treated lambs (p = 0.028, and p = 0.023 respectively); there was no difference in these parameters between ventilated groups. Levels of mRNA for CTGF were not significantly different between groups (control, 1.0 ± 0.13; vehicle-treated, 6.7 ± 2.8; hAEC-treated, 8.3 ± 7.9).

Fig 5.

Lung tissue mRNA levels of IL-1β (A), IL-6 (B), CYR61 (C) and EGR1 (D) in lung tissue from unventilated control lambs (grey bars; n = 5), and vehicle- (white bars; n = 6) and hAEC-treated (black bars; n = 4) lambs. Data were analysed by one-way ANOVA with bonferroni post hoc analysis: P values relate to comparisons with the control group. Data are mean ± SEM.

Fig 6. Interleukin (IL)-8 gene and protein expression.

Messenger RNA (mRNA) levels (relative to control; A) and numbers of IL-8 immunostained cells in lung tissue from unventilated controls (grey bars; n = 8), and vehicle- (white bars; n = 7) and hAEC-treated (black bars; n = 6) lambs. P values relate to comparisons with the control group. Data are mean ± SEM.

Lung histology and immunohistochemistry

Alveolar wall thickness (p = 0.013; Fig 7A), haemorrhage (p = 0.017; Fig 7B), and epithelial sloughing (p = 0.003; Fig 7C) scores were higher in vehicle-treated lambs than in unventilated control lambs: scores in hAEC-treated lambs were intermediate between control and vehicle-treated groups.

Fig 7. Histological assessments of lung injury.

Alveolar wall thickness (A), haemorrhage (B), epithelial sloughing (C), and CD45+ cell counts (D) in lung tissue from unventilated controls (grey bars; n = 5), and vehicle- (white bars; n = 8) and hAEC-treated (black bars; n = 6) lambs. P values relate to comparisons with the control group. Data are mean ± SEM.

The numbers of CD45+ cells in the parenchyma of the right upper lung lobe examined were higher in hAEC-treated lambs than in vehicle-treated lambs (p = 0.008; Fig 7D). Numbers of CD45+ cells in lung tissue from vehicle-treated lambs were intermediate.

Numbers of IL-8+ cells were higher in vehicle- and hAEC-treated lambs than in unventilated controls (p = 0.03 and p = 0.004, respectively) but were not different between ventilated groups (Fig 6B).

Systemic indices of inflammation and immune activation

Hepatic levels of mRNA for SAA-3 were approximately 7-fold higher in vehicle-treated lambs than in unventilated controls and 12-fold higher than in controls in hAEC-treated lambs (p = 0.06 and p = 0.033 respectively; data not shown), but there was no difference between ventilated groups. Hepatic hepcidin and CRP mRNA levels were not different between the 3 groups of lambs (data not shown).

There was no difference in T cell proliferative responses in cells isolated from PMLN, spleen or blood between the 3 groups of lambs (data shown in S2 Table).


Administration of human amnion epithelial cells modulated the acute lung injury and inflammatory response to mechanical ventilation in preterm newborn lambs. This is the first such study in newborn lambs. Our findings extend our previous reports showing that hAECs can moderate in utero lung inflammation and tissue remodelling caused by in utero ventilation (21) or intra-amniotic LPS injection [18] in fetal sheep, and demonstrate immunomodulation by hAECs newborn preterm lambs in vivo.

Although total immune (CD45+) cell counts were elevated by hAEC administration, histological indices of lung injury were not different between hAEC-treated lambs and unventilated controls, suggesting that recruited CD45+ cells did not cause significant damage to the lungs (at least over the period of our study). The greater infiltration of CD45+ cells into the lungs of hAEC-treated lambs is consistent with our observations of the lungs of fetal sheep exposed to LPS in utero [18]. These observations suggest that hAECs augment inflammatory cell recruitment in response to lung inflammation and injury. We consider these cells are unlikely to be neutrophils because IL-8 was not elevated, as would be a typical response to neutrophilic infiltration [30, 31]. The reduction in IL-8 mRNA in lung tissue in lambs treated with hAECs likely reflects the increased recruitment of CD45+ cells, with the number of IL-8 producing cells remaining constant.

The greater number of CD45+ cells in the lungs of hAEC-treated lambs may reflect an increased recruitment of regulatory T cells (Tregs), consistent with observations in hAEC-treated mice following bleomycin-induced lung injury [32]. Indeed, Tregs are critical for hAEC-induced polarisation of macrophages from an M1 to a reparative M2 type phenotype in adult mice with bleomycin-induced lung injury, and a resultant mitigation of lung fibrosis [32]. The anti-inflammatory cytokine IL-10 (we found that endogenous levels tended to be elevated in plasma of hAEC-treated lambs) also plays a role in alternative activation of M2 macrophages [33]. The limited availability of sheep-specific reagents precluded more detailed immune analyses of the neutrophil, M1/M2 macrophage and Treg populations in the lungs of hAEC-treated lambs. Nonetheless, we consider modulation of the local inflammatory response is the most likely mechanism through which hAECs are protective against acute and longer-term lung injury, rather than through reparation dependent on hAEC engraftment, as has been shown in previous studies [17, 18, 34].

We observed hAEC-induced immunomodulation in the lungs of ventilated lambs. CD44 is an adhesion molecule involved in cell-matrix interactions and immune cell trafficking that plays an important role in repair; as demonstrated in a mouse lung inflammation model [35, 36]. In our study, the increase in CD44 expression on BAL cells collected from all ventilated lambs indicates rapid activation of mechanisms for resolution of tissue damage caused during ventilation. Ventilation also resulted in a significant increase in the percentage of CD21+ B lymphocytes (CD21 is also known as complement receptor type 2, and is expressed on a subpopulation of B cells in sheep), and both CD8+ and CD21+ macrophages, which was not observed in BAL collections from the hAEC-treated lambs. CD8 expression by alveolar macrophages [37] and macrophages involved in traumatic tissue responses [38] has been reported previously, and is linked to a pro-inflammatory pathway of macrophage activation involving TNF and IL-1 cytokine secretion [39]. CD21 is commonly expressed by interdigitating dendritic cells within lymph nodes [40], although expression has also been found on airway dendritic cells in sheep [41]. The decrease in BAL cell CD8 and CD21 expression by hAECs demonstrates modulation of airway inflammation in ventilated lambs. Our observations are in agreement with a recent study showing mesenchymal stem cell (MSC)-mediated immune modulation in the airways involving monocytes/macrophages [42].

Administration of hAECs to mice modulates the immune response to decrease long-term fibrosis and BPD-like lung injury [16, 43, 44] and can repair established lung injury [45]. Our study provides evidence for a role of hAECs in reducing lung tissue injury through acute modulation of local inflammatory responses. Additionally, the local pulmonary inflammatory response to mechanical ventilation may induce inflammation and injury in other organs such as the brain [21]. We showed that hAECs modulate ventilation-induced brain inflammation in the lambs from this study [46]. It is possible that the beneficial effects on the brain are due to initial immunomodulation in the lung, which was the primary site of injury in these experiments. Although we observed no sign of systemic immunomodulation within the relatively brief (2 h) period of this experiment, we consider it possible that longer-term immunomodulation may occur as a result of attenuation of inflammation within the lungs.

Our study showed no overt adverse effects of hAEC administration. However, lung compliance tended lower in hAEC-treated lambs than in vehicle-treated lambs. It is possible that tracheal administration of hAECs results in an acute increase in airway resistance, perhaps by clumping of cells in the airways. We recently showed that hAEC function is not impaired in vitro by surfactant administration [47]: co-administration might thus provide better dispersal of the cells within the lungs, thus avoiding this effect.


The amniotic membrane and hAECs are effective and safe for therapeutic use in adults, in whom they have been used mainly for burn treatment and ocular repair for some time [48, 49]. Administration of hAECs, in our current study and in previous experiments undertaken by us, reduces lung injury and fibrotic BPD-like injury through immune modulation. Thus, hAECs may be a viable clinical therapy for neonatal pulmonary injury and prevention of bronchopulmonary dysplasia in preterm human neonates.

Supporting information

S1 Table. Plasma TNF and IL-6 concentrations.



The authors thank Hui Lu and Karyn Rogers for expert technical assistance, and Joanne Mockler for consenting patients for amnion tissue collection.

Author Contributions

  1. Conceptualization: GRP EMW GJ TJM.
  2. Data curation: JMM RJB TJM.
  3. Formal analysis: JMM RJB TJM.
  4. Funding acquisition: EMW GJ TJM.
  5. Investigation: JMM CAM GRP TJM.
  6. Methodology: JMM CAM RJB GRP RL TJM.
  7. Project administration: TJM.
  8. Resources: RJB GRP RL EMW TJM.
  9. Supervision: RJB EMW GJ TJM.
  10. Visualization: JMM RJB TJM.
  11. Writing – original draft: JMM RJB TJM.
  12. Writing – review & editing: JMM CAM RJB GRP RL EMW GJ TJM.


  1. 1. ILCOR. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: neonatal resuscitation. Pediatrics 2006, 117:e978–988. pmid:16618791
  2. 2. Li Z, Zeki R, Hilder L, Sullivan E: Australia's mothers and babies 2011. Perinatal Statistics Series; AIHW National Perinatal Epidemiology and Statistics Unit 2013, 28.
  3. 3. Attar MA, Donn SM. Mechanisms of ventilator-induced lung injury in premature infants. Seminars in Neonatology 2002, 7:353–360. pmid:12464497
  4. 4. Gien J, Kinsella JP: Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 2011, 23:305–313. pmid:21494147
  5. 5. Hillman NH, Polglase GR, Pillow JJ, Saito M, Kallapur SG, Jobe AH. Inflammation and lung maturation from stretch injury in preterm fetal sheep. American Journal of Physiology—Lung Cellular & Molecular Physiology 2011, 300:L232–241.
  6. 6. Wallace MJ, Probyn ME, Zahra VA, Crossley K, Cole TJ, Davis PG, et al. Early biomarkers and potential mediators of ventilation-induced lung injury in very preterm lambs. Respir Res 2009, 10:19. pmid:19284536
  7. 7. Turunen R, Vaarala O, Nupponen I, Kajantie E, Siitonen S, Lano A, et al. Activation of T cells in preterm infants with respiratory distress syndrome. Neonatology 2009, 96:248–258. pmid:19468239
  8. 8. Ballabh P, Simm M, Kumari J, Krauss AN, Jain A, Auld PA, et al. Lymphocyte subpopulations in bronchopulmonary dysplasia. Am J Perinatol 2003, 20:465–475. pmid:14703595
  9. 9. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1995, 72:F90–96. pmid:7712280
  10. 10. Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008, 93:F455–461. pmid:18676410
  11. 11. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 163:1723–1729. pmid:11401896
  12. 12. Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, Evangelista M, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 2008, 26:300–311. pmid:17975221
  13. 13. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC. Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005, 23:1549–1559. pmid:16081662
  14. 14. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biology of Reproduction 2007, 77:577–588. pmid:17494917
  15. 15. Murphy SV, Lim R, Heraud P, Cholewa M, Le Gros M, de Jonge MD, et al. Human amnion epithelial cells induced to express functional cystic fibrosis transmembrane conductance regulator. PLoS ONE 2012, 7:e46533. pmid:23029546
  16. 16. Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, Atienza D, Williams ED, et al. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. American Journal of Respiratory & Critical Care Medicine 2010, 182:643–651.
  17. 17. Hodges RJ, Jenkin G, Hooper SB, Allison B, Lim R, Dickinson H, et al. Human amnion epithelial cells reduce ventilation-induced preterm lung injury in fetal sheep. American Journal of Obstetrics & Gynecology 2012, 206:448 e448–448 e415.
  18. 18. Vosdoganes P, Hodges RJ, Lim R, Westover AJ, Acharya RY, Wallace EM, et al. Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep. American Journal of Obstetrics and Gynecology 2011, 205:156.e126–156.e133.
  19. 19. Vosdoganes P, Lim R, Koulaeva E, Chan ST, Acharya R, Moss TJM, et al. Human amnion epithelial cells modulate hyperoxia-induced neonatal lung injury in mice. Cytotherapy 2013.
  20. 20. Murphy S, Rosli S, Acharya R, Mathias L, Lim R, Wallace E, et al. Amnion epithelial cell isolation and characterization for clinical use. Curr Protoc Stem Cell Biol 2010, Chapter 1:Unit 1E 6.
  21. 21. Polglase GR, Miller SL, Barton SK, Baburamani AA, Wong FY, Aridas JD, et al. Initiation of resuscitation with high tidal volumes causes cerebral hemodynamic disturbance, brain inflammation and injury in preterm lambs. PLoS One 2012, 7:e39535. pmid:22761816
  22. 22. Moss TJM, Nitsos I, Knox CL, Polglase GR, Kallapur SG, Ikegami M, et al. Ureaplasma colonization of amniotic fluid and efficacy of antenatal corticosteroids for preterm lung maturation in sheep. American Journal of Obstetrics & Gynecology 2009, 200.
  23. 23. Polglase GR, Barton SK, Melville JM, Zahra V, Wallace MJ, Siew ML, et al. Prophylactic erythropoietin exacerbates ventilation-induced lung inflammation and injury in preterm lambs. J Physiol 2014, 592:1993–2002. pmid:24591575
  24. 24. Westover AJ, Hooper SB, Wallace MJ, Moss TJ. Prostaglandins mediate the fetal pulmonary response to intrauterine inflammation. American Journal of Physiology—Lung Cellular & Molecular Physiology 2012, 302:L664–678.
  25. 25. Bischof RJ, Snibson K, Shaw R, Meeusen EN. Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite. Clin Exp Allergy 2003, 33:367–375. pmid:12614452
  26. 26. Bischof RJ, Snibson KJ, Van Der Velden J, Meeusen EN. Immune response to allergens in sheep sensitized to house dust mite. J Inflamm (Lond) 2008, 5:16.
  27. 27. Abeynaike L, Meeusen ENT, Bischof RJ. An ovine tracheal explant culture model for allergic airway inflammation. J Inflamm (Lond) 2010, 7:46–55.
  28. 28. Liravi B, Piedrafita D, Nguyen G, Bischof RJ. Dynamics of IL-4 and IL-13 expression in the airways of sheep following allergen challenge. BMC Pulmonary Medicine 2015, 15:1–11.
  29. 29. Kwong LS, Hope JC, Thom ML, Sopp P, Duggan S, Bembridge GP, et al. Development of an ELISA for bovine IL-10. Vet Immunol Immunopathol 2002, 85:213–223. pmid:11943322
  30. 30. Gahler A, Stallmach T, Schwaller J, Fey MF, Tobler A. Interleukin-8 expression by fetal and neonatal pulmonary cells in hyaline membrane disease and amniotic infection. Pediatr Res 2000, 48:299–303. pmid:10960493
  31. 31. Naik AS, Kallapur SG, Bachurski CJ, Jobe AH, Michna J, Kramer BW, et al. Effects of ventilation with different positive end-expiratory pressures on cytokine expression in the preterm lamb lung. Am J Respir Crit Care Med 2001, 164:494–498. pmid:11500356
  32. 32. Tan JL, Chan ST, Lo CY, Deane JA, McDonald CA, Bernard CC, et al. Amnion cell mediated immune modulation following bleomycin challenge: controlling the regulatory T cell response. Stem Cell Res Ther 2015, 6:8. pmid:25634246
  33. 33. Makita N, Hizukuri Y, Yamashiro K, Murakawa M, Hayashi Y. IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration. Int Immunol 2014.
  34. 34. Yawno T, Schuilwerve J, Moss TJ, Vosdoganes P, Westover AJ, Afandi E, et al. Human amnion epithelial cells reduce fetal brain injury in response to intrauterine inflammation. Dev Neurosci 2013, 35:272–282. pmid:23571644
  35. 35. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, et al. Resolution of lung inflammation by CD44. Science 2002, 296:155–158. pmid:11935029
  36. 36. van der Windt GJ, Schouten M, Zeerleder S, Florquin S, van der Poll T. CD44 is protective during hyperoxia-induced lung injury. Am J Respir Cell Mol Biol 2011, 44:377–383. pmid:20463290
  37. 37. Hirji N, Lin TJ, Befus AD. A novel CD8 molecule expressed by alveolar and peritoneal macrophages stimulates nitric oxide production. J Immunol 1997, 158:1833–1840. pmid:9029123
  38. 38. Hiraki K, Park IK, Kohyama K, Matsumoto Y. Characterization of CD8-positive macrophages infiltrating the central nervous system of rats with chronic autoimmune encephalomyelitis. J Neurosci Res 2009, 87:1175–1184. pmid:18951531
  39. 39. Lin TJ, Hirji N, Stenton GR, Gilchrist M, Grill BJ, Schreiber AD, et al. Activation of macrophage CD8: pharmacological studies of TNF and IL-1 beta production. J Immunol 2000, 164:1783–1792. pmid:10657625
  40. 40. Herrmann LM, Cheevers WP, Davis WC, Knowles DP, O'Rourke KI. CD21-positive follicular dendritic cells: A possible source of PrPSc in lymph node macrophages of scrapie-infected sheep. Am J Pathol 2003, 162:1075–1081. pmid:12651600
  41. 41. Gulbahar MY, Davis WC, Yarim M, Guvenc T, Umur S, Kabak YB, et al. Characterization of local immune response against lungworms in naturally infected sheep. Vet Parasitol 2009, 160:272–278. pmid:19108954
  42. 42. Ko JH, Lee HJ, Jeong HJ, Kim MK, Wee WR, Yoon SO, et al. Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye. Proc Natl Acad Sci U S A 2016, 113:158–163. pmid:26699483
  43. 43. Murphy S, Lim R, Dickinson H, Acharya R, Rosli S, Jenkin G, et al. Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function. Cell Transplant 2011, 20:909–923. pmid:21092408
  44. 44. Murphy SV, Shiyun SC, Tan JL, Chan S, Jenkin G, Wallace EM, et al. Human amnion epithelial cells do not abrogate pulmonary fibrosis in mice with impaired macrophage function. Cell Transplant 2012, 21:1477–1492. pmid:22507554
  45. 45. Vosdoganes P, Wallace EM, Chan ST, Acharya R, Moss TJ, Lim R. Human amnion epithelial cells repair established lung injury. Cell Transplant 2012.
  46. 46. Barton SK, Melville JM, Tolcos M, Polglase GR, McDougall AR, Azhan A, et al. Human Amnion Epithelial Cells Modulate Ventilation-Induced White Matter Pathology in Preterm Lambs. Dev Neurosci 2015.
  47. 47. McDonald CA, Melville JM, Polglase GR, Jenkin G, Moss TJ. Maintenance of human amnion epithelial cell phenotype in pulmonary surfactant. Stem Cell Res Ther 2014, 5:107. pmid:25189170
  48. 48. Azuara-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 1999, 83:399–402. pmid:10434859
  49. 49. Stern M. The grafting of preserved amniotic membrane to burned and ulcerated surfaces, substituing skin grafts: A preliminary report. Journal of the American Medical Association 1913, 60:973–974.